Impact of hyperbaric oxygen therapy on the... (2008 study) Skip to main content
Clinical Trial Anesteziol Reanimatol 2008

Impact of hyperbaric oxygen therapy on the clinical course of acute pancreatitis and systemic inflammation response syndrome

Lisagors I, Sondore A, Pupelis G, Oshs P, Iaunalksne I, Pavars M, et al., Anesteziol Reanimatol, 2008

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers compared 22 acute pancreatitis patients who received hyperbaric oxygen therapy (HBO) alongside standard treatment with 22 patients who received standard treatment alone.

What They Found

In a prospective, controlled study of 44 patients with acute pancreatitis, the HBO group was reported to have more stable homeostasis, a lower mortality rate and fewer operations than the control group. All patients showed systemic inflammatory response syndrome on admission. The treatment group received HBO for 3 days, twice a day, in a monoplace chamber at 1.7-1.9 ATA. The authors said HBO possibly contributed to lower intraabdominal pressure within the first six days after admission. They also said the findings suggest HBO can affect the inflammatory response, with lower pro-inflammatory cytokines and higher anti-inflammatory ones. The abstract gives no mortality figures, no p-values and no cytokine values.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The study was small, with 22 patients per group, and the abstract does not say patients were randomly assigned. It gives no statistical tests or numbers for the group differences, so the reported benefits cannot be judged from the abstract alone.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Trial
Category Uncategorised
Source Pubmed
PubMed ID 18819393
Year Published 2008
Journal Anesteziol Reanimatol
MeSH Terms Biomarkers; Female; Humans; Hyperbaric Oxygenation; Interleukin-6; Kinetics; Male; Middle Aged; Pancreatitis; Prospective Studies; Receptors, Tumor Necrosis Factor, Type II; Severity of Illness Index; Systemic Inflammatory Response Syndrome; Time Factors; Treatment Outcome

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology